Arambagh Apexx Diagnostic And Health Care Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 16-07-2024
- Paid Up Capital ₹ 2.20 Cr
as on 16-07-2024
- Company Age 11 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.90 Cr
as on 16-07-2024
- Revenue 7.71%
(FY 2023)
- Profit -460.86%
(FY 2023)
- Ebitda -78.37%
(FY 2023)
- Net Worth -98.31%
(FY 2023)
- Total Assets -1.20%
(FY 2023)
About Arambagh Apexx Diagnostic And Health Care
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.20 Cr.
The company currently has active open charges totaling ₹3.90 Cr.
Lailun Begam, Mohammad Rahamani, and Mufti Jamal serve as directors at the Company.
- CIN/LLPIN
U85100WB2013PTC195870
- Company No.
195870
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jul 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Arambagh, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Arambagh Apexx Diagnostic And Health Care?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lailun Begam  | Director | 25-Jul-2013 | Current |
| Mohammad Rahamani | Director | 25-Jul-2013 | Current |
| Mufti Jamal | Director | 25-Jul-2013 | Current |
Financial Performance of Arambagh Apexx Diagnostic And Health Care.
Arambagh Apexx Diagnostic And Health Care Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.71% increase. The company also saw a substantial fall in profitability, with a 460.86% decrease in profit. The company's net worth observed a substantial decline by a decrease of 98.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arambagh Apexx Diagnostic And Health Care?
In 2023, Arambagh Apexx Diagnostic And Health Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
West Bengal Financial Corporation Creation Date: 31 Dec 2015 | ₹3.90 Cr | Open |
How Many Employees Work at Arambagh Apexx Diagnostic And Health Care?
Arambagh Apexx Diagnostic And Health Care has a workforce of 10 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arambagh Apexx Diagnostic And Health Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arambagh Apexx Diagnostic And Health Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
